cpasstm sars-cov-2 neutralization antibody detection kit l00847-c (GenScript corporation)
90
Structured Review
GenScript corporation
cpasstm sars-cov-2 neutralization antibody detection kit l00847-c
Cpasstm Sars Cov 2 Neutralization Antibody Detection Kit L00847 C, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpasstm+sars-cov-2+neutralization+antibody+detection+kit+l00847-c/surrogate+virus+neutralization+test/med_rxiv__2022__03__22__22272739-65-44-45
Average 90 stars, based on 1 article reviews
Cpasstm Sars Cov 2 Neutralization Antibody Detection Kit L00847 C, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpasstm+sars-cov-2+neutralization+antibody+detection+kit+l00847-c/surrogate+virus+neutralization+test/med_rxiv__2022__03__22__22272739-65-44-45
Average 90 stars, based on 1 article reviews
cpasstm sars-cov-2 neutralization antibody detection kit l00847-c - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Plaque Reduction Neutralization Test:Article Title: The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial Article Snippet: Secondary outcomes were neutralizing antibody titer evaluated by a 50 percent (50%) plaque reduction neutralization test (PRNT 50 ) using the original (Wuhan) strain, Variant Assay:Article Title: The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial Article Snippet: Secondary outcomes were neutralizing antibody titer evaluated by a 50 percent (50%) plaque reduction neutralization test (PRNT 50 ) using the original (Wuhan) strain, Competitive ELISA:Article Title: The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial Article Snippet: Secondary outcomes were neutralizing antibody titer evaluated by a 50 percent (50%) plaque reduction neutralization test (PRNT 50 ) using the original (Wuhan) strain, Enzyme-linked Immunosorbent Assay:Article Title: The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial Article Snippet: Secondary outcomes were neutralizing antibody titer evaluated by a 50 percent (50%) plaque reduction neutralization test (PRNT 50 ) using the original (Wuhan) strain, Virus:Article Title: The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial Article Snippet: Secondary outcomes were neutralizing antibody titer evaluated by a 50 percent (50%) plaque reduction neutralization test (PRNT 50 ) using the original (Wuhan) strain, Neutralization:Article Title: The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial Article Snippet: Secondary outcomes were neutralizing antibody titer evaluated by a 50 percent (50%) plaque reduction neutralization test (PRNT 50 ) using the original (Wuhan) strain, |